The Three Most Important Messages for Parents of a Child with Facial Infantile Hemangioma

Authors

  • A. Diociaiuti Dermatology Unit and Genodermatosis Research Unit Translational Paediatrics and Clinical Genetics Research Division Bambino Gesù Children’s Hospital IRCCS Rome Italy

Keywords:

Infantile Hemangioma, Vascular tumors, Beta-blocker, Propranolol

Abstract

Infantile hemangioma (IH) is the most common vascular tumor affecting infants.
The most IH lesions follow a benign and self-limited course. Facial IHs
are especially concerning because of their potential functional impairment
and psychosocial impact. The author illustrates the main useful information
to help families understand the nature of this injury, its progression over time
and the therapeutic management options.

Downloads

Download data is not yet available.

Author Biography

A. Diociaiuti, Dermatology Unit and Genodermatosis Research Unit Translational Paediatrics and Clinical Genetics Research Division Bambino Gesù Children’s Hospital IRCCS Rome Italy

Corresponding author:

Andrea Diociaiuti,
Dermatologist,
Dermatology Unit and Genodermatosis
Research Unit, Translational Paediatrics
and Clinical Genetics Research
Division, Bambino Gesù Children’s
Hospital IRCCS, Rome, Italy
andrea.diociaiuti@opbg.net

Published

2026-01-14

How to Cite

Diociaiuti, A. (2026). The Three Most Important Messages for Parents of a Child with Facial Infantile Hemangioma. International Journal of Pediatric Dermatology, 2(3), 32–35. Retrieved from https://scientificeditorial.com/index.php/IJPD/article/view/Parents-of-a-Child-with-Facial-Infantile-Hemangioma

Issue

Vol. 2 No. 3 (2025): International Journal of Pediatric Dermatology. Special Issue

Section

NARRATIVE REVIEW
Copyright & Licensing